NCT07375875Completed
Strategies to Minimize the Risk for Insulin Induced Hypertrophy and Its Related Consequences
Source: ClinicalTrials.gov · Last updated 29 Jan 2026
Brief summary (registry, in English)
Hypertrophy caused by insulin has effects that extend beyond just aesthetic concerns. Innovative methods have shown potential in decreasing the chances of hypertrophy and its related issues, including the development of detailed diagrams of insulin injection locations and tailored rotation plans. This study aimed to assess the impact of a novel insulin injection sites map (digital or physical) on the incidence of insulin-induced hypertrophy, adherence to rotation protocols, glycemic control, and patient experience among diabetes patients treated with insulin between study and control group along six months of follow up
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 170 (actual)
- First submitted
- 22 Jan 2026
- Start date
- 15 May 2025
- Primary completion date
- 15 Dec 2025
- Lead sponsor
- Mansoura University
- Diseases
- Type 1 diabetes
- NCT number
- NCT07375875
What you commit to
- Study type: Interventional
- Participants enrolled: 170
- From 15 May 2025 to the primary completion date, 15 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with mental illnesses or severe cognitive impairment.
- Individuals with skin disorders at injection locations such as severe eczema, psoriasis, or infection that could interfere with the evaluation of lipohypertrophy.
- Women who are lactating or pregnant.
Who the study is looking for
- • Type 1 or type 2 diabetes mellitus in adults (≥18 years old).
- Insulin therapy has been administered for a minimum of six months.
- Self-injecting insulin and assisted injection on a regular basis
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| faculty of nursing, Mansoura university Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.